Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Return on Assets [ROA] (2012 - 2026)

Updated

Grace Therapeutics (GRCE) recorded Return on Assets [ROA] of -39.74% in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 28.27 percentage points from -11.47% a year earlier and down 5.09 percentage points from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Return on Assets [ROA] (2012 - 2026) Analysis & Trends

For FY2026 (ended Mar 31, 2026), Grace Therapeutics reported Return on Assets [ROA] of -11.24%, up 1.93 percentage points from FY2025.

  • Annual Return on Assets [ROA] has increased for three straight fiscal years, with a five-year change of +34.89 percentage points (FY2021 to FY2026).
  • Across earlier fiscal years, Return on Assets [ROA] came in at -13.17% in FY2025 (+3.69 pp), -16.86% in FY2024 (+23.98 pp), -40.85% in FY2023 (-30.57 pp) and -10.28% in FY2022 (+35.85 pp).
  • The fiscal Q2 2027 figure is the lowest quarterly Return on Assets [ROA] since fiscal Q3 2024.
  • On a year-over-year basis, Return on Assets [ROA] rose in six of the last eight quarters, with an average year-over-year change of +0.73 percentage points.
  • Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 39.10 percentage points in fiscal Q1 2025, against a drop of 46.26 percentage points in fiscal Q1 2024 at the low end.
  • Per Business Quant, the preceding three fiscal quarters came in at -34.65% (Q1 2027), -11.53% (Q4 2026) and -8.85% (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 8.08%
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 7.32%
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 1.87%
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 9.36%
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 9.80%
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -7.67%
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 2.00%
10 Grace Therapeutics 35.10 Mn -35.61 Mn - -39.74%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -39.74%
Jun 30, 2026 -34.65%
Mar 31, 2026 -11.53%
Dec 31, 2025 -8.85%
Sep 30, 2025 -11.47%
Jun 30, 2025 -14.55%
Mar 31, 2025 -14.36%
Dec 31, 2024 -21.13%
Sep 30, 2024 -17.19%
Jun 30, 2024 -16.01%
Mar 31, 2024 -17.20%
Dec 31, 2023 -50.23%
Sep 30, 2023 -53.25%
Jun 30, 2023 -55.11%
Mar 31, 2023 -43.31%
Dec 31, 2022 -14.51%
Sep 30, 2022 -13.94%
Jun 30, 2022 -8.85%
Mar 31, 2022 -8.09%
Dec 31, 2021 -9.88%
API Access

Grace Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=GRCE&period=max&api_key=YOUR_API_KEY